Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China. According to data from DealForma, as reported by CNBC ...

Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Growth Investor model based on the published strategy of ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 44.7% year on year to $13.53 billion. The company’s full-year revenue ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) met Wall Street’s revenue expectations in ... and its $13.53 billion of revenue was in line with Wall Street’s estimates. Looking ahead, sell-side ...

Eli Lilly expects 2024 revenue to be $45 billion, with Mounjaro and Zepbound sales contributing significantly. The company aims to increase Zepbound’s market share, competing with Novo Nordisk ...

Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 earnings figures before tomorrow’s bell. Given recent price action ...

scouring the internet for 6.6 Duramax fuel consumption figures in real-world driving conditions. One owner of a third-generation 2006 LBZ – the very engine that gave the 6.6 Duramax an edge ...

The Department of Mineral and Petroleum Resources has announced the official fuel price adjustments for February, with significant increases confirmed for both petrol and diesel. From Wednesday ...